Literature DB >> 30872795

Hypoxia-induced tumor exosomes promote M2-like macrophage polarization of infiltrating myeloid cells and microRNA-mediated metabolic shift.

Jung Eun Park1, Bamaprasad Dutta2, Shun Wilford Tse2, Nikhil Gupta2, Chee Fan Tan2, Jee Keem Low3, Kheng Wei Yeoh4, Oi Lian Kon5, James P Tam2, Siu Kwan Sze6.   

Abstract

Developing tumors rapidly outgrow their oxygen supply and are subject to hypoxia, which stimulates hypersecretion of tumor-derived exosomes that promote angiogenesis, metastasis, and immunosuppression, but the molecular mediators of these pathological effects remain poorly defined. Using quantitative proteomics, we identified that exosomes produced by hypoxic tumor cells are highly enriched in immunomodulatory proteins and chemokines including CSF-1, CCL2, FTH, FTL, and TGFβ. Modeling exosome effects on tumor-infiltrating immune cells, we observed a potent ability of these hypoxia-induced vesicles to influence macrophage recruitment and promote M2-like polarization both in vitro and in vivo. In addition, hypoxic, but not normoxic, tumor exosomes enhanced oxidative phosphorylation in bone marrow-derived macrophages via transfer of let-7a miRNA, resulting in suppression of the insulin-Akt-mTOR signaling pathway. Together, these data demonstrate that hypoxia promotes tumor secretion of biomolecule-loaded exosomes that can modify the immunometabolic profile of infiltrating monocyte-macrophages to better evade host immunity and enhance tumor progression.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30872795     DOI: 10.1038/s41388-019-0782-x

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  79 in total

Review 1.  Metabolic Reprogramming of Immune Cells in Cancer Progression.

Authors:  Subhra K Biswas
Journal:  Immunity       Date:  2015-09-15       Impact factor: 31.745

Review 2.  Leukotriene A4 hydrolase: an emerging target of natural products for cancer chemoprevention and chemotherapy.

Authors:  Tam Thuy Lu Vo; Won-Jun Jang; Chul-Ho Jeong
Journal:  Ann N Y Acad Sci       Date:  2018-07-29       Impact factor: 5.691

Review 3.  HIF-1 and tumor progression: pathophysiology and therapeutics.

Authors:  Gregg L Semenza
Journal:  Trends Mol Med       Date:  2002       Impact factor: 11.951

4.  Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II.

Authors:  J Kao; K Houck; Y Fan; I Haehnel; S K Libutti; M L Kayton; T Grikscheit; J Chabot; R Nowygrod; S Greenberg
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

Review 5.  The significance of ferritin in cancer: anti-oxidation, inflammation and tumorigenesis.

Authors:  Ahmed A Alkhateeb; James R Connor
Journal:  Biochim Biophys Acta       Date:  2013-07-25

6.  The Lin28/let-7 axis regulates glucose metabolism.

Authors:  Hao Zhu; Ng Shyh-Chang; Ayellet V Segrè; Gen Shinoda; Samar P Shah; William S Einhorn; Ayumu Takeuchi; Jesse M Engreitz; John P Hagan; Michael G Kharas; Achia Urbach; James E Thornton; Robinson Triboulet; Richard I Gregory; David Altshuler; George Q Daley
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

Review 7.  Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms.

Authors:  Tamás Rőszer
Journal:  Mediators Inflamm       Date:  2015-05-18       Impact factor: 4.711

Review 8.  Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications.

Authors:  Julieta De Toro; Leticia Herschlik; Claudia Waldner; Claudia Mongini
Journal:  Front Immunol       Date:  2015-05-04       Impact factor: 7.561

9.  Stromal-cell and cancer-cell exosomes leading the metastatic exodus for the promised niche.

Authors:  Robert M Hoffman
Journal:  Breast Cancer Res       Date:  2013-06-18       Impact factor: 6.466

Review 10.  Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity.

Authors:  Louise A Elliott; Glen A Doherty; Kieran Sheahan; Elizabeth J Ryan
Journal:  Front Immunol       Date:  2017-02-06       Impact factor: 7.561

View more
  96 in total

Review 1.  The application of nanotechnology in enhancing immunotherapy for cancer treatment: current effects and perspective.

Authors:  Yongjiang Li; Ciceron Ayala-Orozco; Pradipta Ranjan Rauta; Sunil Krishnan
Journal:  Nanoscale       Date:  2019-09-18       Impact factor: 7.790

2.  Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs.

Authors:  Mahendran Chinnappan; Akhil Srivastava; Narsireddy Amreddy; Mohammad Razaq; Vipul Pareek; Rebaz Ahmed; Meghna Mehta; Jo Elle Peterson; Anupama Munshi; Rajagopal Ramesh
Journal:  Cancer Lett       Date:  2020-05-19       Impact factor: 8.679

Review 3.  Myeloid cell-targeted therapies for solid tumours.

Authors:  Sangeeta Goswami; Swetha Anandhan; Deblina Raychaudhuri; Padmanee Sharma
Journal:  Nat Rev Immunol       Date:  2022-06-13       Impact factor: 53.106

Review 4.  Exosomal non-coding RNAs: Emerging roles in bilateral communication between cancer cells and macrophages.

Authors:  Wenhao Li; Xiaolong Wang; Chen Li; Tong Chen; Qifeng Yang
Journal:  Mol Ther       Date:  2021-12-02       Impact factor: 11.454

Review 5.  Phenotypic plasticity of myeloid cells in glioblastoma development, progression, and therapeutics.

Authors:  Zengpanpan Ye; Xiaolin Ai; Linjie Zhao; Fan Fei; Ping Wang; Shengtao Zhou
Journal:  Oncogene       Date:  2021-09-23       Impact factor: 9.867

Review 6.  MicroRNAs in tumor immunity: functional regulation in tumor-associated macrophages.

Authors:  Chong Chen; Jia-Ming Liu; Yun-Ping Luo
Journal:  J Zhejiang Univ Sci B       Date:  2020 Jan.       Impact factor: 3.066

7.  Metabolically engineered stem cell-derived exosomes to regulate macrophage heterogeneity in rheumatoid arthritis.

Authors:  Dong Gil You; Gyeong Taek Lim; Seunglee Kwon; Wooram Um; Byeong Hoon Oh; Seok Ho Song; Jungmi Lee; Dong-Gyu Jo; Yong Woo Cho; Jae Hyung Park
Journal:  Sci Adv       Date:  2021-06-02       Impact factor: 14.136

Review 8.  Exosomes in the lung cancer microenvironment: biological functions and potential use as clinical biomarkers.

Authors:  Runzhi Qi; Yuwei Zhao; Qiujun Guo; Xue Mi; Mengqi Cheng; Wei Hou; Honggang Zheng; Baojin Hua
Journal:  Cancer Cell Int       Date:  2021-06-30       Impact factor: 5.722

9.  Exosome to Promote Cancer Progression via Its Bioactive Cargoes.

Authors:  Austin McMasters; Kelly M McMasters; Hongying Hao
Journal:  Arch Cancer Biol Ther       Date:  2021-06

10.  Hypoxic TAM-derived exosomal miR-155-5p promotes RCC progression through HuR-dependent IGF1R/AKT/PI3K pathway.

Authors:  Wenyu Gu; Linjing Gong; Xu Wu; Xudong Yao
Journal:  Cell Death Discov       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.